Literature DB >> 31406929

Endoscopic shielding using oxidized regenerated cellulose after argon plasma coagulation under mandatory dual antiplatelet therapy.

Vincent Zimmer1,2.   

Abstract

Endoscopic shielding is an innovative concept in therapeutic endoscopy. Its usage has been mostly restricted to wide-field endoscopic mucosal resection and/or endoscopic submucosal dissection. A novel potential clinical use may be in bleeding pophylaxis for argon plasma coagulation-related ulcers under concomitant mandatory dual antiplatelet therapy.

Entities:  

Keywords:  angiodysplasia; argon plasma coagulation; colonoscopy; dual antiplatelet therapy; endoscopic shielding; gastrointestinal bleeding

Year:  2019        PMID: 31406929      PMCID: PMC6684507          DOI: 10.1002/jgh3.12135

Source DB:  PubMed          Journal:  JGH Open        ISSN: 2397-9070


While in broad clinical use in many fields of surgery, endoscopic shielding is considered quite a novel concept in interventional endoscopy, for example, for large postresectional lesions [endoscopic submucosal dissection (ESD) and/or endoscopic mucosal resection (EMR)], with available data indicating prevention of late perforation and/or bleeding as well as accelerated tissue repair/healing.1 Apart from polyglycolic acid (PGA) sheets, another biocompatible, naturally absorbable hemostatic substance for endoscopic applications is oxidized regenerated cellulose, which is less expensive and more broadly available.2 Apart from endoscopic shielding for endoscopic resection procedures, there is an ever‐increasing set of clinical applications in interventional endoscopy reported, including perforation and/or fistula closure, difficult‐to‐treat bleeding situations, and—among others—stricture prevention following esophageal ESD procedures.3, 4, 5 However, argon plasma coagulation (APC), for which endoscopic shielding has not yet been reported, is by itself considered a low‐risk procedure in terms of bleeding in recent guidelines, however, clinical caution is mandatory in the presence of dual antiplatelet therapy (DAPT). Delayed bleeding and/or perforation after APC application, especially in the cecal pole, may occur and may have deleterious consequences in patients with recent coronary stent interventions. From such reasoning, here, the first report on preventive endoscopic shielding of an APC site in such a complex clinical setting is presented. Of note, mandatory DAPT indications are becoming more and more common in increasingly aging populations with a high comorbidity of advanced cardiovascular disease and colorectal angiodysplasia. Two months after non‐ST segment‐elevation myocardial infarction treated by coronary recanalization using two drug‐eluting stents (DES), a 63‐year‐old man presented for recurrent gastrointestinal bleeding and iron deficiency anemia. Endoscopic work‐up including small‐bowel capsule endoscopy indicated a cecal angiodysplasia as the most likely bleeding source under DAPT with ticagrelor and aspirin. After adequate counseling, APC was performed using low‐power 20 W settings (Fig. 1a). The APC‐induced ulcer was subsequently provided with two individually trimmed 20 × 20‐mm measuring oxidized regenerated cellulose gauzes (Tabotamp, Ethicon, Norderstedt, Germany), the polymers of which swell into a gelatinous mass with hemostatic and antibacterial effects, introduced through the working channel by a standard forceps. After adequate adaptation (Fig. 1b), two standard clips were used to attach the gauzes in place. The further clinical course was uncomplicated.
Figure 1

(a) Illustration of the APC treated angiodysplasia in the cecal pole with shallow ulcerations. (b) Gauzes of oxidized regenerated cellulose were applied to the APC site after external grasping and delivery by a standard forceps. APC, argon plasma coagulation.

(a) Illustration of the APC treated angiodysplasia in the cecal pole with shallow ulcerations. (b) Gauzes of oxidized regenerated cellulose were applied to the APC site after external grasping and delivery by a standard forceps. APC, argon plasma coagulation. Endoscopic shielding following APC for angiodysplasia has not yet been reported and may represent a reasonable approach to increasing the safety of APC in DAPT patients, although this clinical assumption may warrant formal systematic study. Many reports on endoscopic shielding have implemented complex delivery approaches, particularly for coverage of extensive mucosal defects, for example, utilizing specialized catheters and standard additional fibrin glue (FG) spraying through specialized catheters with or without clipping, rendering the procedure potentially high‐cost, time‐consuming, and complex.6, 7 However, in clinical situations with limited mucosal areas to be covered, the need for FG utilization may become questioned, and standard biopsy forceps delivery followed by clip fixation is considered a more straightforward and easy‐to‐implement approach for endoscopic shielding using oxidized regenerated cellulose in more circumscribed endoscopic situations.
  7 in total

1.  A new technique for delivering a polyglycolic acid sheet to cover a large mucosal defect: the Swiss roll method.

Authors:  Kunihiro Tsuji; Hisashi Doyama; Hiroyoshi Nakanishi; Kazuhiro Matsunaga; Shinya Yamada
Journal:  Endoscopy       Date:  2014-11-19       Impact factor: 10.093

2.  Gastrointestinal hemorrhage caused by the direct invasion of a hepatocellular carcinoma successfully treated with polyglycolic acid sheet shielding.

Authors:  Tomohiko Mannami; Nobukiyo Fujiwara; Genyo Ikeda; Takahito Mishima; Taiga Kuroi; Takayuki Muraoka; Yasuyuki Ohtawa
Journal:  Endoscopy       Date:  2018-11-23       Impact factor: 10.093

3.  Enormous postoperative perforation after endoscopic submucosal dissection for duodenal cancer successfully treated with filling and shielding by polyglycolic acid sheets with fibrin glue and computed tomography-guided abscess puncture.

Authors:  Yoshiko Ohara; Kengo Takimoto; Takashi Toyonaga; Tomohiro Yamaguchi; Hiroya Sakaguchi; Fumiaki Kawara; Shinwa Tanaka; Tsukasa Ishida; Yoshinori Morita; Eiji Umegaki
Journal:  Clin J Gastroenterol       Date:  2017-11-01

4.  Effectiveness of Surgicel® (Fibrillar) in patients with colorectal endoscopic submucosal dissection.

Authors:  Yu Sik Myung; Bong Min Ko; Jae Pil Han; Su Jin Hong; Seong Ran Jeon; Jin Oh Kim; Jong Ho Moon; Moon Sung Lee
Journal:  Surg Endosc       Date:  2015-07-23       Impact factor: 4.584

5.  Polyglycolic acid sheet and fibrin glue for preventing esophageal stricture after endoscopic submucosal dissection: a historical control study.

Authors:  T Iizuka; D Kikuchi; S Hoteya; Y Kajiyama; M Kaise
Journal:  Dis Esophagus       Date:  2017-11-01       Impact factor: 3.429

6.  Endoscopic shielding technique, a new method in therapeutic endoscopy.

Authors:  Ignacio Bon; Ramon Bartolí; Vicente Lorenzo-Zúñiga
Journal:  World J Gastroenterol       Date:  2017-06-07       Impact factor: 5.742

7.  Endoscopic closure of an anastomo-cutaneous fistula: Filling and shielding using polyglycolic acid sheets and fibrin glue with easily deliverable technique.

Authors:  Hideaki Kawabata; Yuji Okazaki; Naonori Inoue; Yukino Kawakatsu; Misuzu Hitomi; Masatoshi Miyata; Shigehiro Motoi
Journal:  Endosc Int Open       Date:  2018-08-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.